Literature DB >> 28419858

Reply.

Aylin Tansel1, David Y Graham1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28419858      PMCID： PMC6903698          DOI： 10.1016/j.cgh.2017.04.018

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  7 in total

Review 1.  Review article: immediate-release proton-pump inhibitor therapy--potential advantages.

Authors:  C W Howden
Journal:  Aliment Pharmacol Ther       Date:  2005-12       Impact factor: 8.171

2.  Administration of proton pump inhibitors in patients requiring enteral nutrition.

Authors:  Terri M Wensel
Journal:  P T       Date:  2009-03

3.  Open vs Intact Proton Pump Inhibitor Capsules for Treatment of Marginal Ulcers.

Authors:  Colin W Howden
Journal:  Clin Gastroenterol Hepatol       Date:  2017-04-02       Impact factor: 11.382

4.  Healing Marginal Ulcers in Patients Who Have Had a Roux-en-Y Gastric Bypass.

Authors:  Paul N Maton
Journal:  Clin Gastroenterol Hepatol       Date:  2017-04-23       Impact factor: 11.382

5.  New Insight Into an Effective Treatment of Marginal Ulceration After Roux-en-Y Gastric Bypass.

Authors:  Aylin Tansel; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2017-01-03       Impact factor: 11.382

6.  Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass.

Authors:  Allison R Schulman; Walter W Chan; Aiofe Devery; Michele B Ryan; Christopher C Thompson
Journal:  Clin Gastroenterol Hepatol       Date:  2016-10-20       Impact factor: 11.382

7.  Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

Authors:  T Lind; C Cederberg; G Ekenved; U Haglund; L Olbe
Journal:  Gut       Date:  1983-04       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.